Back to results
US 12,655,409 B2Granted
Recombinant lysin and its use in the treatment of Gram-negative bacterial infections
AssigneeTelum Therapeutics S.L.
InventorsRoberto Díez Martínez, María Morales Areizaga
Life of this patent
Estimating the term…
Abstract
The present invention relates to a recombinant lysin and its use as antimicrobial agent in new treatment approaches for eliminating antibiotic resistant Gram-negative bacteria, and minimizing the emergence of new resistances. It further concerns polynucleotides encoding the recombinant lysin of the invention, vectors and host cells comprising the same, as well as related methods, medical uses, compositions and kits.
Claims21
A chimeric protein consisting of amino acid sequence SEQ ID NO:
- 5.
Dependencies are inferred from the claim text.